全文获取类型
收费全文 | 4725篇 |
免费 | 291篇 |
出版年
2022年 | 26篇 |
2021年 | 38篇 |
2020年 | 26篇 |
2019年 | 48篇 |
2018年 | 64篇 |
2017年 | 63篇 |
2016年 | 90篇 |
2015年 | 153篇 |
2014年 | 181篇 |
2013年 | 265篇 |
2012年 | 287篇 |
2011年 | 299篇 |
2010年 | 187篇 |
2009年 | 185篇 |
2008年 | 292篇 |
2007年 | 259篇 |
2006年 | 293篇 |
2005年 | 281篇 |
2004年 | 265篇 |
2003年 | 247篇 |
2002年 | 253篇 |
2001年 | 99篇 |
2000年 | 102篇 |
1999年 | 91篇 |
1998年 | 70篇 |
1997年 | 58篇 |
1996年 | 53篇 |
1995年 | 47篇 |
1994年 | 41篇 |
1993年 | 36篇 |
1992年 | 53篇 |
1991年 | 56篇 |
1990年 | 47篇 |
1989年 | 38篇 |
1988年 | 36篇 |
1987年 | 28篇 |
1986年 | 32篇 |
1985年 | 30篇 |
1984年 | 34篇 |
1983年 | 37篇 |
1982年 | 16篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 20篇 |
1978年 | 15篇 |
1976年 | 17篇 |
1975年 | 15篇 |
1974年 | 14篇 |
1970年 | 10篇 |
1968年 | 15篇 |
排序方式: 共有5016条查询结果,搜索用时 15 毫秒
121.
122.
Noboru Asada Yoshio Katayama Mari Sato Kentaro Minagawa Kanako Wakahashi Hiroki Kawano Yuko Kawano Akiko Sada Kyoji Ikeda Toshimitsu Matsui Mitsune Tanimoto 《Cell Stem Cell》2013,12(6):737-747
- Download : Download high-res image (522KB)
- Download : Download full-size image
123.
124.
Rai Dilip Toshiyuki Ishii Hideki Imada Yuko Wada-Kiyama Ryoiti Kiyama Eiichi Miyachi Makoto Kaneda 《Journal of molecular histology》2013,44(6):639-644
There is increasing evidence that ATP acts on purinergic receptors and mediates synaptic transmission in the retina. In a previous study, we raised the possibility that P2X-purinoceptors, presumably P2X2-purinoceptors in OFF-cholinergic amacrine cells, play a key role in the formation of OFF pathway-specific modulation. In this study, we examined whether the P2Y1-purinoceptors can function in cholinergic amacrine cells in the mouse retina since cholinergic amacrine cells in the rat retina express P2Y1-purinoceptors. P2Y1-purinoceptors were shown to be expressed in dendrites of both ON- and OFF-cholinergic amacrine cells in adults. At postnatal day 7, there was immunoreactivity for P2Y1-purinoceptors in the soma of cholinergic amacrine cells. At postnatal day 14, weak immunoreactivity for P2Y1-purinoceptors was detected in the dendrites but not in the soma of cholinergic amacrine cells. At postnatal day 21, strong immunoreactivity for P2Y1-purinoceptors was detected in dendrites of cholinergic amacrine cells. The expression pattern of P2Y1-purinoceptors was not affected by visual experience. We concluded that P2Y1-purinoceptors are not involved in the OFF-pathway-specific signal transmission in cholinergic amacrine cells of the mouse retina. 相似文献
125.
The navel orangeworm, Amyelois transitella is a major agricultural pest causing large losses in a variety of tree crops. Control of this insect pest may be achieved by interfering with olfactory pathways to block detection of female-produced sex pheromones and consequently, disrupt mating. The first component of this pathway is the pheromone-binding protein AtraPBP1, which recognizes the pheromone and presents it to the odorant receptor housed in a sensory neuron of the male antennae. Release of the ligand depends on a pH-induced conformational change associated with the acidity of the membrane surface. To characterize this conformational change and to understand how pheromones bind, we have determined the high resolution crystal structures of AtraPBP1 in complex with two main constituents of the sex pheromone, i.e., (11Z,13Z)-hexadecadienal and (11Z,13Z)-hexadecadienol. Comparison with the structure of the unliganded form demonstrates a large ∼90° movement of the C-terminal helix which is observed in other pheromone- or odorant-binding proteins accompanied by an unpredicted 37° displacement of the N-terminal helix. Molecular dynamic trajectories suggest that the conformational change of the α1 helix facilitates the movement of the C-terminal helix. 相似文献
126.
Masaaki Konishi Seigo Sugiyama Koichi Sugamura Toshimitsu Nozaki Keisuke Ohba Junichi Matsubara Kenji Sakamoto Yasuhiro Nagayoshi Hitoshi Sumida Eiichi Akiyama Yasushi Matsuzawa Kentaro Sakamaki Satoshi Morita Kazuo Kimura Satoshi Umemura Hisao Ogawa 《PloS one》2013,8(4)
Background
Cardiac troponin is a specific biomarker for cardiomyocyte necrosis in acute coronary syndromes. Troponin release from the coronary circulation remains to be determined because of the lower sensitivity of the conventional assay. We sought to determine basal and angina-induced troponin release using a highly sensitive troponin assay.Methods and Results
The cardiac troponin T levels in serum sampled from the peripheral vein (PV), the aortic root (AO), and the coronary sinus (CS) were measured in 105 consecutive stable patients with coronary risk factor(s) and suspected coronary artery disease (CAD) and in 33 patients without CAD who underwent an acetylcholine provocation test. At baseline, there was a significant increase in the troponin levels from AO [9.0 (6.4, 13.1) pg/mL for median (25th, 75th percentiles)] to CS [10.3 (7.3, 15.5) pg/mL, p<0.001] in 96 (91.4%) patients and the difference was 1.1 (0.4, 2.1) pg/mL, which reflected basal transcardiac troponin release (TTR). TTR was positively correlated with PV levels (r = 0.22, p = 0.03). Male sex, left ventricular hypertrophy determined by echocardiography, T-wave inversion, and CAD correlated with elevated TTR defined as above: median, 1.1 pg/mL. A significant increase in TTR was noted in 17 patients with coronary spasms [0.6 (0.2, 1.2) pg/mL, p<0.01] but not in 16 patients without spasms [0.0 (−0.5, 0.9) pg/mL, p = 0.73] after the acetylcholine provocation.Conclusion
Basal TTR in the coronary circulation was observed in most of the patients with suspected CAD and risk factor(s). This sensitive assay detected myocardial ischemia-induced increases in TTR caused by coronary spasms. 相似文献127.
Masashi Kitagawa Hitoshi Sugiyama Hiroshi Morinaga Tatsuyuki Inoue Keiichi Takiue Ayu Ogawa Toshio Yamanari Yoko Kikumoto Haruhito Adam Uchida Shinji Kitamura Yohei Maeshima Kazufumi Nakamura Hiroshi Ito Hirofumi Makino 《PloS one》2013,8(2)
Background
Klotho was originally identified in a mutant mouse strain unable to express the gene that consequently showed shortened life spans. In humans, low serum Klotho levels are related to the prevalence of cardiovascular diseases in community-dwelling adults. However, it is unclear whether the serum Klotho levels are associated with signs of vascular dysfunction such as arterial stiffness, a major determinant of prognosis, in human subjects with chronic kidney disease (CKD).Methods
We determined the levels of serum soluble Klotho in 114 patients with CKD using ELISA and investigated the relationship between the level of Klotho and markers of CKD-mineral and bone disorder (CKD-MBD) and various types of vascular dysfunction, including flow-mediated dilatation, a marker of endothelial dysfunction, ankle-brachial pulse wave velocity (baPWV), a marker of arterial stiffness, intima-media thickness (IMT), a marker of atherosclerosis, and the aortic calcification index (ACI), a marker of vascular calcification.Results
The serum Klotho level significantly correlated with the 1,25-dihydroxyvitamin D level and inversely correlated with the parathyroid hormone level and the fractional excretion of phosphate. There were significant decreases in serum Klotho in patients with arterial stiffness defined as baPWV≥1400 cm/sec, atherosclerosis defined as maximum IMT≥1.1 mm and vascular calcification scores of ACI>0%. The serum Klotho level was a significant determinant of arterial stiffness, but not endothelial dysfunction, atherosclerosis or vascular calcification, in the multivariate analysis in either metabolic model, the CKD model or the CKD-MBD model. The adjusted odds ratio of serum Klotho for the baPWV was 0.60 (p = 0.0075).Conclusions
Decreases in the serum soluble Klotho levels are independently associated with signs of vascular dysfunction such as arterial stiffness in patients with CKD. Further research exploring whether therapeutic approaches to maintain or elevate the Klotho level could improve arterial stiffness in CKD patients is warranted. 相似文献128.
Jacqueline M. Chaparro Dayakar V. Badri Matthew G. Bakker Akifumi Sugiyama Daniel K. Manter Jorge M. Vivanco 《PloS one》2013,8(2)
Plant roots constantly secrete compounds into the soil to interact with neighboring organisms presumably to gain certain functional advantages at different stages of development. Accordingly, it has been hypothesized that the phytochemical composition present in the root exudates changes over the course of the lifespan of a plant. Here, root exudates of in vitro grown Arabidopsis plants were collected at different developmental stages and analyzed using GC-MS. Principle component analysis revealed that the composition of root exudates varied at each developmental stage. Cumulative secretion levels of sugars and sugar alcohols were higher in early time points and decreased through development. In contrast, the cumulative secretion levels of amino acids and phenolics increased over time. The expression in roots of genes involved in biosynthesis and transportation of compounds represented in the root exudates were consistent with patterns of root exudation. Correlation analyses were performed of the in vitro root exudation patterns with the functional capacity of the rhizosphere microbiome to metabolize these compounds at different developmental stages of Arabidopsis grown in natural soils. Pyrosequencing of rhizosphere mRNA revealed strong correlations (p<0.05) between microbial functional genes involved in the metabolism of carbohydrates, amino acids and secondary metabolites with the corresponding compounds released by the roots at particular stages of plant development. In summary, our results suggest that the root exudation process of phytochemicals follows a developmental pattern that is genetically programmed. 相似文献
129.
Introduction
Patients with schizophrenia elicit cognitive decline from the early phase of the illness. Mismatch negativity (MMN) has been shown to be associated with cognitive function. We investigated the current source density of duration mismatch negativity (dMMN), by using low-resolution brain electromagnetic tomography (LORETA), and neuropsychological performance in subjects with early schizophrenia.Methods
Data were obtained from 20 patients meeting DSM-IV criteria for schizophrenia or schizophreniform disorder, and 20 healthy control (HC) subjects. An auditory odd-ball paradigm was used to measure dMMN. Neuropsychological performance was evaluated by the brief assessment of cognition in schizophrenia Japanese version (BACS-J).Results
Patients showed smaller dMMN amplitudes than those in the HC subjects. LORETA current density for dMMN was significantly lower in patients compared to HC subjects, especially in the temporal lobes. dMMN current density in the frontal lobe was positively correlated with working memory performance in patients.Conclusions
This is the first study to identify brain regions showing smaller dMMN current density in early schizophrenia. Further, poor working memory was associated with decreased dMMN current density in patients. These results are likely to help understand the neural basis for cognitive impairment of schizophrenia. 相似文献130.
Kohei Shigeta Tetsu Hayashida Yoshinori Hoshino Koji Okabayashi Takashi Endo Yoshiyuki Ishii Hirotoshi Hasegawa Yuko Kitagawa 《PloS one》2013,8(6)
Cetuximab is a chimeric mouse–human monoclonal antibody that targets the human epidermal growth factor receptor (EGFR). However, EGFR expression determined by immunohistochemistry does not predict clinical outcomes of colorectal cancer (CRC) patients treated with cetuximab. Therefore, we evaluated the correlation between EGFR levels detected by cetuximab and drug sensitivities of CRC cell lines (Caco-2, WiDR, SW480, and HCT116) and the A431 epidermoid carcinoma cell line. We used flow cytometry (FCM) to detect EGFR-binding of biotinylated cetuximab on the cell surface. Subcloned cell lines showing the highest and lowest EGFR expression levels were chosen for further study. Cytotoxic assays were used to determine differential responses to cetuximab. Xenograft models treated with cetuximab intraperitoneally to assess sensitivity to cetuximab. Strong responses to cetuximab were specifically exhibited by subcloned cells with high EGFR expression levels. Furthermore, cetuximab inhibited the growth of tumors in xenograft models with high or low EGFR expression levels by 35% and 10%–20%, respectively. We conclude that detection of EGFR expression by cetuximab promises to provide a novel, sensitive, and specific method for predicting the sensitivity of CRC to cetuximab. 相似文献